Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2014, Zoic Capital is a venture capital firm based in the United States that focuses on early-stage health technology startups. The firm was established to address the systematic underfunding of health technology ventures, particularly those that leverage hard science and possess strong intellectual property. Zoic Capital aims to support the development of innovative solutions to global challenges, particularly in the healthcare sector.
Currently, Zoic Capital operates with a team of experienced professionals and has a significant focus on investing in Seed to Series A stages. The firm emphasizes the importance of market validation and transformative technologies that address well-defined problems with measurable impacts. Their investment strategy is designed to identify and support startups that are poised to make a significant difference in the healthcare landscape.
Zoic Capital invests primarily in early-stage ventures, specifically from Seed to Series A stages. The firm concentrates on the first three rounds of capital, targeting healthcare and frontier technologies that are backed by robust intellectual property. Their investment thesis highlights the importance of market validation and the potential for transformative technologies that can address well-defined problems.
Investment criteria include a strong emphasis on feasibility, with a preference for technologies that are entering the regulatory approval phase. Zoic Capital seeks to partner with experienced teams and focuses on platform technologies rather than single-product plays. This approach allows them to differentiate themselves in a competitive market, particularly in the underfunded segment of early-stage medical devices.
While specific names and descriptions of portfolio companies were not provided in the source material, Zoic Capital has invested in, incubated, or founded several notable companies in the healthcare sector. Some of the highlighted companies include:
Additional medical technology companies are listed on their website, indicating a diverse portfolio that aligns with their investment focus on health technology and frontier innovations.
Neal Mody - Managing Director. Neal leads the firm and has extensive experience in venture capital and health technology investments.
Ian Eliason - Partner. Ian brings a wealth of knowledge in early-stage investing and has been instrumental in sourcing new deals for the firm.
Adrian Berliner - Partner. Adrian oversees new investments and deal sourcing, reviewing over 1,000 health startups annually.
Shayan Bhattacharyya - Venture Partner. Shayan contributes expertise in health technology and supports portfolio companies with strategic guidance.
Lahav Gil - Venture Partner. Lahav is involved in mentoring and advising portfolio companies, leveraging his background in healthcare innovation.
To pitch Zoic Capital, founders should submit their applications through the firm's website at zoiccapital.com. It is essential to include a comprehensive deck that outlines the technology, market validation, and the founding team’s expertise. The firm prefers to receive pitches through this channel and values clear, concise presentations.
Response times may vary, but founders should expect a thorough review process given the high volume of applications. Warm introductions can enhance the chances of receiving a timely response.
In recent months, Zoic Capital has been active in the healthcare investment space. Notably, they led a $3M raise for HDT Bio Corp., a company focused on vaccine and biopharma development. Additionally, they participated in the seed round for ChromaTan Technologies, which specializes in continuous bioprocessing for biologics purification.
The firm continues to seek opportunities in the medical device sector, actively engaging in seed and bridge rounds to support innovative health technology startups.
What are Zoic Capital's investment criteria?
Zoic Capital focuses on early-stage health technology startups, particularly those with strong intellectual property and market validation. They invest in ventures from Seed to Series A stages, emphasizing transformative technologies that address well-defined problems.
How can I apply or pitch to Zoic Capital?
Founders can submit funding applications through Zoic Capital's application page at zoiccapital.com. It is recommended to include detailed information about the technology, market validation, and the team.
What makes Zoic Capital different from other investors?
Zoic Capital differentiates itself by focusing on underfunded segments of the health technology market, particularly early-stage medical devices. Their emphasis on platform technologies and strong intellectual property sets them apart from generalist VCs.
What is the geographic scope of Zoic Capital's investments?
Zoic Capital primarily invests in the United States, with some interest in Canadian ventures. Their focus is on health technology startups that can demonstrate significant market potential.
What is the typical check size for investments?
Zoic Capital typically invests between $500K and $10M per investment, aligning with their focus on early-to-growth stage companies. They have led rounds and participated as syndicate members in various funding activities.
What kind of post-investment support does Zoic Capital provide?
Zoic Capital utilizes a network of venture partners to mentor and advise portfolio companies, providing access to clinical and operational expertise. This support is crucial for navigating the challenges of the healthcare sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.